Due to the large numbers of patients that have been helped by CABG surgery in past years, there is a large pool of patients with diseased SVG bypass vessels in need of this procedure.
For more information about Saphenous Vein Graft Disease see: http://www.americanheart.org
About Nfocus Neuromedical, Inc.
Nfocus is a neurovascular development, manufacturing and marketing company focused on treating hemorrhagic stroke. Current and future product programs are aimed at rapid treatment of aneurysms and fistulas in the brain. Nfocus also has developed the CardioVasc(TM) Stent-graft for specific applications within the coronary artery disease market. Based in Palo Alto, California, Nfocus is privately held and venture capital backed. See http://www.nfocusneuro.com for further information.
| SOURCE Nfocus Neuromedical, Inc. Copyright©2008 PR Newswire. All rights reserved |